Form 4 Absci Corp For: 6 July
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Absci Corp (ABSI)
Track today's live Absci (ABSI) share price, performance and key data on this page with our current NASDAQ:ABSI stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Absci share price on the NASDAQ exchange. Use the dropdown to switch exchange for the ABSI share price, head to our technical summary section, which provides analysis on Absci share price buy/sell indicators using real-time data (or discuss the Absci (ABSI) stock price today with other investors in the Absci NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:ABSI share price (ISIN: US00091E1091) to enhance your trading decisions with our free investment tools and resources.
What Is the Absci Corp Share Price Today?
The Absci share price today is 11.750.
What Is the Stock Symbol for Absci Corp
The stock symbol (or 'ticker') for Absci Corp is "ABSI."
What Stock Exchange Does Absci Corp Trade On?
Absci Corp is listed and trades on the NASDAQ stock exchange.
Is Absci Corp a Good Stock to Buy?
Determining whether Absci (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:ABSI share price (ISIN: US00091E1091) to enhance your trading decisions with our free investment tools and resources.
What Is the Absci Corp Share Price Today?
The Absci share price today is 11.750.
What Is the Stock Symbol for Absci Corp
The stock symbol (or 'ticker') for Absci Corp is "ABSI."
What Stock Exchange Does Absci Corp Trade On?
Absci Corp is listed and trades on the NASDAQ stock exchange.
Is Absci Corp a Good Stock to Buy?
Determining whether Absci (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
11.500
+0.400(+3.60%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.900
12.000
52 wk Range
2.240
12.055
ABSI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.90012.000
52 wk Range
2.24012.055
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ABSI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
13.778
Upside
+19.81%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock price movements are quite volatile
- Absci director Mary T Szela buys $148,866 in stock
- Investing.com
- Form 4 Absci Corp For: 26 June
- Investing.com
- Form 4 Absci Corp For: 6 July
- Investing.com
- Absci director Mary T Szela buys $148,866 in stock
- Investing.com
- Absci receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
9 Buy
1 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 13.778
(+19.81% Upside)
Absci Corp Earnings Call Summary for Q1/2026
- Absci posted Q1 2026 revenue of $215K, missing forecast of $1.43M by 85%; EPS of -$0.19 beat estimate of -$0.1943 by 2.21%
- R&D expenses rose 17.7% YoY to $19.3M; company maintains $125.7M cash position, sufficient to fund operations into H1 2028
- Stock declined 0.84% after-hours to $5.90 but rebounded 1.53% in premarket; trades near 52-week high with 115% annual return
- ABS-201 program for androgenetic alopecia targets interim proof-of-concept data in H2 2026, full results expected early 2027
- Management pursuing strategic pharma partnerships for non-dilutive funding; analysts maintain Buy rating with price targets of $4.20-$12.00
Last Updated: 11/05/2026, 16:56
Read Full TranscriptEarnings
Latest Release
07/05/2026
EPS / Forecast
-0.19 / -0.19
Revenue / Forecast
215K / 1.43M
Compare ABSI to Peers and Sector
Metrics to compare | ABSI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipABSIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −15.9x | −4.3x | −0.4x | |
PEG Ratio | −1.47 | −0.08 | 0.00 | |
Price/Book | 10.9x | 2.2x | 2.6x | |
Price / LTM Sales | 1,024.2x | 96.3x | 3.0x | |
Upside (Analyst Target) | 17.1% | 110.7% | 51.9% | |
Fair Value Upside | Unlock | −4.5% | 9.4% | Unlock |
Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Absci (NASDAQ: ABSI) Share Price Today?
The Absci stock price today is 11.500 USD.
What Stock Exchange Does Absci (ABSI) Trade On?
Absci is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Absci?
The stock symbol (also called a 'ticker') for Absci is "ABSI."
What Is the Current Absci Market Capitalisation?
As of today, Absci (NASDAQ: ABSI) market cap is 1.940B USD.
What Is Absci's (ABSI) Earnings Per Share (TTM)?
The Absci EPS is currently -0.823 (Trailing Twelve Months).
When Is the Next Absci Earnings Date?
Absci's next earnings report will be released on 18/08/2026.
Is ABSI a Buy or Sell From a Technical Analyst Perspective?
Based on today's Absci moving averages and other technical indicators, the daily buy/sell signal for ABSI stock is Strong Buy.
How Many Times Has Absci Stock Split?
Absci has split 0 times. (See the ABSI stock split history page for full effective split date and price information.)
How Many Employees Does Absci Have?
Absci has 140 employees, based on their latest Companies House report.
What is the current trading status of Absci (NASDAQ: ABSI)?
As of 09/07/2026, Absci (ABSI) is trading at a share price of 11.500 USD, with a previous close of 11.100 USD. The stock has fluctuated within a day range of 10.900 USD to 12.000 USD, while its 52-week range spans from 2.240 USD to 12.055 USD.
What Is Absci (ABSI) Price Target According to Analysts?
The average 12-month price target for Absci is 13.778 USD, with a high estimate of 17 USD and a low estimate of 10 USD. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +19.81% Upside potential.
What Is the ABSI Premarket Price?
ABSI's last pre-market stock price is 11.284 USD. The pre-market share volume is 18,070.000, and the stock has decreased by 0.184, or 1.660%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.